Eden review
You pay a premium per month, but you buy back certainty: all-50 access and high-disclosure clinical oversight that hold their value.
- Semaglutide
- $239/mo
- Tirzepatide
- $349/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
Semaglutide · modeled / year
$2,868
Tirzepatide · modeled / year
$4,188
The Index scorecard
Eden scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- High transparency — clear supply-chain and clinician disclosure lowers hidden-cost risk
- Nationwide availability with both molecules disclosed
- Strong clinical oversight adds value beyond the raw price
The tradeoffs
- Premium per-month cost drags its normalized value score
- Compounded only — no brand-name access
The bottom line
Best for: People who will trade a higher sticker price for verified nationwide access and stronger clinical oversight. You pay a premium per month, but you buy back certainty: all-50 access and high-disclosure clinical oversight that hold their value.
Ranked #4 of 9 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 8 other providers we've modeled, in Cost-Efficiency Index order.
- #1CoreAge Rx— Best value on the board: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser.94/100
- #2Invigor Medical— Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog.88/100
- #3ShedRx— The lowest published tirzepatide cost among our partners, plus an oral/sublingual route — strong cost-per-month for the needle-averse.87/100
- #5AgelessRx— The lowest published semaglutide cost on the board, with some brand-name access — but an undisclosed tirzepatide price leaves a hole in the value model.85/100
- #6Found— The cheapest identical price on both molecules nationwide — unbeatable raw cost-per-month, capped only by a coaching subscription you can't fully unbundle.88/100
- #7Ro— The widest formulary — brand-name and oral access — but opaque compounded pricing means you can't model the value until you're already in the funnel.84/100
- #8Hims & Hers— Nationwide reach and a slick app at a mid-market semaglutide price — but an undisclosed tirzepatide price leaves part of the value equation blank.83/100
- #9Henry Meds— A transparent flat-fee pioneer — the pricing is clean and modelable, but it now sits at the higher end, so the value per dollar has slipped.81/100
Pricing, states and verification reflect Eden's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Eden's site. Not medical advice; see our disclosure.